Following actinomycin D treatment, knockdown of LINC01419 or YBX1 accelerated but overexpression of LINC01419 or YBX1 retarded PDK1 degradation in HCC cells (Figure 4A; Figure S7B). This evidence concerns the gene YBX1 and hepatocellular carcinoma.